SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Optimer Pharmaceuticals, Inc. and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand